Search results
FDA: Avoid These Dairy Products During the Current Bird Flu Outbreak
Prevention· 7 days agoThe FDA reported which dairy products are safe to eat amid the recent bird flu outbreak. Bird flu...
FDA extends review of Ascendis Pharma's hypoparathyroidism drug By Investing.com
Investing.com· 14 hours agoAscendis Pharma A/S (NASDAQ:ASND), a biopharmaceutical company, has received notice from the U.S....
US FDA extends review of Ascendis Pharma's hormone disorder therapy
Reuters via AOL· 14 hours agoU.S.-listed shares of the company were down 6.6% in late afternoon trading. The health regulator...
FDA said it "never" inspected dental lab that made controversial AGGA device
CBS News· 2 days agoThe FDA never inspected Johns Dental Laboratories during more than a decade in which it made the...
Eisai initiates rolling Biologics License Application to US FDA for Leqembi® (lecanemab-irmb) for...
WROC Rochester· 6 hours agoFood and Drug Administration (FDA) for lecanemab-irmb (U.S. brand name: Leqembi) subcutaneous...
FDA issues ‘most serious type of recall’ involving app-reliant insulin pumps
WPIX New York City, NY via Yahoo News· 23 hours agoThe U.S. Food and Drug Administration has issued a recall correction for an Apple iOS app used with...
Roche says FDA approves HPV self-test in US
Reuters via Yahoo News· 4 hours agoBERLIN (Reuters) - Swiss drugmaker Roche on Wednesday said the US Food and Drug Administration (FDA) has approved its human papillomavirus (HPV)...
FDA issues warning to Cue Health over COVID-19 test By Investing.com
Investing.com· 1 day agoCue Health Inc. (NASDAQ:HLTH), a healthcare technology company, has received a warning letter from...
FDA warns users not to use Cue Health’s at-home Covid-19 tests
Medical Device Network via Yahoo Finance· 22 hours agoThe US Food and Drug Administration (FDA) has warned users not to use Cue Health’s at-home Covid-19...
New Clozapine Data Suggest FDA Should Ease Restrictions
Medscape· 4 hours agoThe risk for severe neutropenia with clozapine is minimal, suggesting that burdensome FDA-required hematologic monitoring should be relaxed, researchers said.